These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30998329)

  • 21. Amine linked flavonoid dimers as modulators for P-glycoprotein-based multidrug resistance: structure-activity relationship and mechanism of modulation.
    Chan KF; Wong IL; Kan JW; Yan CS; Chow LM; Chan TH
    J Med Chem; 2012 Mar; 55(5):1999-2014. PubMed ID: 22320402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function.
    Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC
    Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antitumor agents 286. Design, synthesis, and structure-activity relationships of 3'R,4'R-disubstituted-2',2'-dimethyldihydropyrano[2,3-f]chromone (DSP) analogues as potent chemosensitizers to overcome multidrug resistance.
    Zhou T; Shi Q; Bastow KF; Lee KH
    J Med Chem; 2010 Dec; 53(24):8700-8. PubMed ID: 21082774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting P-Glycoprotein: Nelfinavir Reverses Adriamycin Resistance in K562/ADR Cells.
    Liu W; Meng Q; Sun Y; Wang C; Huo X; Liu Z; Sun P; Sun H; Ma X; Liu K
    Cell Physiol Biochem; 2018; 51(4):1616-1631. PubMed ID: 30497065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An organoruthenium complex overcomes ABCG2-mediated multidrug resistance via multiple mechanisms.
    Zeng L; Li J; Zhang C; Zhang YK; Zhang W; Huang J; Ashby CR; Chen ZS; Chao H
    Chem Commun (Camb); 2019 Mar; 55(26):3833-3836. PubMed ID: 30869688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 1-[4-(2-Aminoethoxy)phenylcarbonyl]-3,5-bis-(benzylidene)-4-oxopiperidines: a novel series of highly potent revertants of P-glycoprotein associated multidrug resistance.
    Das U; Molnár J; Baráth Z; Bata Z; Dimmock JR
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3484-7. PubMed ID: 18513966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parguerenes: Marine red alga bromoditerpenes as inhibitors of P-glycoprotein (ABCB1) in multidrug resistant human cancer cells.
    Huang XC; Sun YL; Salim AA; Chen ZS; Capon RJ
    Biochem Pharmacol; 2013 May; 85(9):1257-68. PubMed ID: 23415901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 6-(7-Nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol, a specific glutathione S-transferase inhibitor, overcomes the multidrug resistance (MDR)-associated protein 1-mediated MDR in small cell lung cancer.
    Filomeni G; Turella P; Dupuis ML; Forini O; Ciriolo MR; Cianfriglia M; Pezzola S; Federici G; Caccuri AM
    Mol Cancer Ther; 2008 Feb; 7(2):371-9. PubMed ID: 18281520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oleanolic acid derivative methyl 3,11-dioxoolean-12-en-28-olate targets multidrug resistance related to ABCB1.
    Paszel A; Rubiś B; Bednarczyk-Cwynar B; Zaprutko L; Kaczmarek M; Hofmann J; Rybczyńska M
    Pharmacol Rep; 2011; 63(6):1500-17. PubMed ID: 22358098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolonged inhibition of P-glycoprotein after exposure to chemotherapeutics increases cell mortality in multidrug resistant cultured cancer cells.
    Nanayakkara AK; Vogel PD; Wise JG
    PLoS One; 2019; 14(6):e0217940. PubMed ID: 31173617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multidrug resistance reversal activity of key ningalin analogues.
    Soenen DR; Hwang I; Hedrick MP; Boger DL
    Bioorg Med Chem Lett; 2003 May; 13(10):1777-81. PubMed ID: 12729663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Constituents and Anti-Multidrug Resistance Activity of
    Hung HY; Hung CC; Liang JW; Chen CF; Chen HY; Shieh PC; Kuo PC; Wu TS
    Molecules; 2019 Oct; 24(20):. PubMed ID: 31623176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversal of multidrug resitance by natural substances from plants.
    Molnár J; Engi H; Hohmann J; Molnár P; Deli J; Wesolowska O; Michalak K; Wang Q
    Curr Top Med Chem; 2010; 10(17):1757-68. PubMed ID: 20645919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of new A- and B-type laxaphycins with synergistic anticancer activity.
    Cai W; Matthew S; Chen QY; Paul VJ; Luesch H
    Bioorg Med Chem; 2018 May; 26(9):2310-2319. PubMed ID: 29606488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis and structure-activity relationships of novel taxane-based multidrug resistance reversal agents.
    Ojima I; Borella CP; Wu X; Bounaud PY; Oderda CF; Sturm M; Miller ML; Chakravarty S; Chen J; Huang Q; Pera P; Brooks TA; Baer MR; Bernacki RJ
    J Med Chem; 2005 Mar; 48(6):2218-28. PubMed ID: 15771464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 3-benzazecine-based cyclic allene derivatives as highly potent P-glycoprotein inhibitors overcoming doxorubicin multidrug resistance.
    Titov AA; Niso M; Candia M; Kobzev MS; Varlamov AV; Borisova TN; Voskressensky LG; Colabufo NA; Cellamare S; Pisani L; Altomare CD
    Future Med Chem; 2019 Aug; 11(16):2095-2106. PubMed ID: 31538529
    [No Abstract]   [Full Text] [Related]  

  • 37. Proteasome inhibitor MG132 reverses multidrug resistance of gastric cancer through enhancing apoptosis and inhibiting P-gp.
    Zhang Y; Shi Y; Li X; Du R; Luo G; Xia L; Du W; Chen B; Zhai H; Wu K; Fan D
    Cancer Biol Ther; 2008 Apr; 7(4):540-6. PubMed ID: 18296917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trichormamides C and D, antiproliferative cyclic lipopeptides from the cultured freshwater cyanobacterium cf. Oscillatoria sp. UIC 10045.
    Luo S; Kang HS; Krunic A; Chen WL; Yang J; Woodard JL; Fuchs JR; Hyun Cho S; Franzblau SG; Swanson SM; Orjala J
    Bioorg Med Chem; 2015 Jul; 23(13):3153-62. PubMed ID: 26001342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of multidrug resistant in cancer cells by EGCG, tannic acid and curcumin.
    Li H; Krstin S; Wink M
    Phytomedicine; 2018 Nov; 50():213-222. PubMed ID: 30466981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acerinol, a cyclolanstane triterpenoid from Cimicifuga acerina, reverses ABCB1-mediated multidrug resistance in HepG2/ADM and MCF-7/ADR cells.
    Liu DL; Li YJ; Yao N; Xu J; Chen ZS; Yiu A; Zhang CX; Ye WC; Zhang DM
    Eur J Pharmacol; 2014 Jun; 733():34-44. PubMed ID: 24704556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.